These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 4008179)

  • 1. Lacrimal gland autoimmunity in New Zealand mice.
    Tabbara KF; Ohashi Y
    Int Ophthalmol Clin; 1985; 25(2):153-63. PubMed ID: 4008179
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The presence of cytotoxic autoantibody to lacrimal gland cells in NZB/W mice.
    Ohashi Y; So SK; Minasi PN; Tabbara KF
    Invest Ophthalmol Vis Sci; 1985 Feb; 26(2):214-9. PubMed ID: 3972503
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lacrimal and salivary gland inflammation in the C3H/Ipr autoimmune strain mouse: a potential mode for Sjögren's syndrome.
    Johnson BC; Morton JI; Trune DR
    Otolaryngol Head Neck Surg; 1992 Apr; 106(4):394-9. PubMed ID: 1565490
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sjögren's syndrome in MRL/l and MRL/n mice.
    Hoffman RW; Alspaugh MA; Waggie KS; Durham JB; Walker SE
    Arthritis Rheum; 1984 Feb; 27(2):157-65. PubMed ID: 6421291
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Submandibular and lacrimal gland immunoglobulin in the C3H.MRL-Faslpr autoimmune mouse model of Sjögren's syndrome.
    Trune DR; Leedy DA
    Laryngoscope; 1998 Nov; 108(11 Pt 1):1729-32. PubMed ID: 9818834
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Murine models of Sjögren's syndrome. Evolution of the lacrimal gland inflammatory lesions.
    Jabs DA; Enger C; Prendergast RA
    Invest Ophthalmol Vis Sci; 1991 Feb; 32(2):371-80. PubMed ID: 1993589
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Influence of androgen therapy on lacrimal autoimmune disease in a mouse model of Sjögren's syndrome.
    Sullivan DA; Rocha FJ; Sato EH
    Adv Exp Med Biol; 1995; 371B():1199-202. PubMed ID: 7502783
    [No Abstract]   [Full Text] [Related]  

  • 8. Th1 versus Th2 immune responses in autoimmune lacrimal gland disease in MRL/Mp mice.
    Jabs DA; Lee B; Whittum-Hudson JA; Prendergast RA
    Invest Ophthalmol Vis Sci; 2000 Mar; 41(3):826-31. PubMed ID: 10711700
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparative influence of steroid hormones and immunosuppressive agents on autoimmune expression in lacrimal glands of a female mouse model of Sjögren's syndrome.
    Sato EH; Sullivan DA
    Invest Ophthalmol Vis Sci; 1994 Apr; 35(5):2632-42. PubMed ID: 8163351
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Electron microscopic findings and cellular immunity of the lacrimal gland in Sjogren's disease].
    Sarata K; Matsuo N; Hasegawa E; Miyagawa K; Kamoi S
    Nihon Rinsho; 1983; 41(2):442-4. PubMed ID: 6865013
    [No Abstract]   [Full Text] [Related]  

  • 11. CD8 T cells contribute to lacrimal gland pathology in the nonobese diabetic mouse model of Sjögren syndrome.
    Barr JY; Wang X; Meyerholz DK; Lieberman SM
    Immunol Cell Biol; 2017 Sep; 95(8):684-694. PubMed ID: 28465508
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Animal models for autoimmune disease-associated xerostomia and xerophthalmia.
    Humphreys-Beher MG
    Adv Dent Res; 1996 Apr; 10(1):73-5. PubMed ID: 8934930
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Presence and testosterone influence on the levels of anti- and pro-inflammatory cytokines in lacrimal tissues of a mouse model of Sjögren's syndrome.
    Rocha EM; Wickham LA; Huang Z; Toda I; Gao J; da Silveira LA; Sullivan DA
    Adv Exp Med Biol; 1998; 438():485-91. PubMed ID: 9634925
    [No Abstract]   [Full Text] [Related]  

  • 14. Different effects on the inflammatory lesions in the lacrimal and salivary glands after neonatal thymectomy in IQI/Jic mice, a model for Sjögren's syndrome.
    Takada K; Takiguchi M; Inaba M
    J Vet Med Sci; 2005 Sep; 67(9):955-7. PubMed ID: 16210812
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Murine models of Sjögren's syndrome.
    Jabs DA; Prendergast RA
    Adv Exp Med Biol; 1994; 350():623-30. PubMed ID: 8030545
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interferon-γ treatment in vitro elicits some of the changes in cathepsin S and antigen presentation characteristic of lacrimal glands and corneas from the NOD mouse model of Sjögren's Syndrome.
    Meng Z; Klinngam W; Edman MC; Hamm-Alvarez SF
    PLoS One; 2017; 12(9):e0184781. PubMed ID: 28902875
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Histopathologic and immunochemical changes in Sjögren's syndrome].
    Wu X; Huang Y; Yao X; Hang Z; Cheng N; Lei S; He G; Li B; Chen C; Mao Z
    Hua Xi Yi Ke Da Xue Xue Bao; 1997 Sep; 28(3):284-7. PubMed ID: 10684035
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Investigations of various animal models for Sjögren's syndrome].
    Hayashi Y
    Nihon Rinsho; 1995 Oct; 53(10):2383-8. PubMed ID: 8531342
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cyclosporine therapy suppresses ocular and lacrimal gland disease in MRL/Mp-lpr/lpr mice.
    Jabs DA; Lee B; Burek CL; Saboori AM; Prendergast RA
    Invest Ophthalmol Vis Sci; 1996 Feb; 37(2):377-83. PubMed ID: 8603842
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A novel lacrimal gland autoantigen in the NOD mouse model of Sjögren's syndrome.
    Esch TR; Poveromo JD; Aikins MC; Levanos VA
    Scand J Immunol; 2002 Mar; 55(3):304-10. PubMed ID: 11940237
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.